Rob Verdijk

Dr. Rob Verdijk is a researcher in the Department of Pathology at Erasmus MC, Netherlands. His work is highly focused on molecular and diagnostic pathology, particularly in the context of uveal melanoma, brain tumors, and rare histiocytic disorders. He is actively contributing to translational research with recent publications in 2025 across leading oncology and neuropathology journals.

His research interests span uveal melanoma genetics, liquid biopsy development, RNA sequencing for prognostic markers, central nervous system tumor pathology, and molecular diagnostics in rare neoplasms. Using advanced genomic and epigenomic tools, his work aims to improve diagnostic accuracy and patient outcomes.

The most recent articles reflect a strong trend in molecular oncology, particularly in leveraging genetic profiling and methylation analysis to understand tumor behavior and guide clinical decisions. His collaborations span neuropathology, oncology, and molecular genetics, indicating an interdisciplinary research profile.

Scientific Awards:

• No awards listed in the provided text.

Dr. Verdijk has supervised at least 3 research projects, as indicated in the profile, and is involved in collaborative research across multiple institutions. While specific grants are not mentioned, his publication output suggests active funding support. He plays a key role in advancing diagnostic paradigms in ocular and neurological cancers.

He is part of a larger research network at Erasmus MC focused on cancer genetics and neuropathology, contributing to both primary research and clinical translation. His work on liquid biopsy and genetic alterations is shaping non-invasive diagnostic approaches in uveal melanoma.